As of Mar 31
| -0.18 / -1.13%|
The 4 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 25.00, with a high estimate of 30.00 and a low estimate of 22.00. The median estimate represents a +59.44% increase from the last price of 15.68.
The current consensus among 5 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.